ARCHIVES

Zofran Label Change Includes Warnings of QT Prolongation

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

DCE Board Approves Recompetition Concepts

March 18, 1988

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

April 30, 2010

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

Murphy Withdraws From SU Position

October 17, 1986